View all newsletters
Receive our newsletter – data, insights and analysis delivered to you


Self-Injection Devices

Haselmeier specialises in the development and manufacture of innovative self-injection devices with proprietary designs and technology.

Vaihinger Strasse 48,
70567 Stuttgart,

Haselmeier specialises in the development and manufacture of innovative self-injection devices with proprietary designs and technology.

The company covers all of the steps in the creation of its award-winning devices from design, to planning and industrialisation.

Haselmeier also offers a range of early-stage development activities to ensure all products are high quality. The company conducts human factors studies and consults with user focus groups to provide successful administration. This is combined with a qualified design control process, certified quality system, regulatory expertise, a solid network of partners, and strong manufacturing operations designed to meet and exceed client expectations.

Self-injection devices for the pharmaceutical industry

Haselmeier has a world-class design and development team that works in compliance with regulatory requirements. The company creates, designs and industrialises self-injection systems used by pharmaceutical and biotechnology companies worldwide.

D-Flex can be configured for several fixed-dose values and is thus a variable fixed-dose pen.
The compact Axis-D Pen system is made from high-quality plastic.
The i-pen is a reusable injection device designed for use with 3ml cartridges.
The i-pen² was designed to provide a cost-effective self-injection device.

Haselmeier creates products to enable a convenient and comfortable experience, which is why patient feedback is integrated into device designs.

Concept and prototype evaluations for pharmaceutical devices

Early concepts are prototyped for testing to ensure high-quality products, while human factor studies capture the handling needs and skills of potential users.

This knowledge is integrated into the design of pharmaceutical devices to provide successful administration of drug products and optimal user experience.

Haselmeier offers a range of early stage activities, including:

  • Think-tank discussions and paper concepts for medical devices
  • Detailed product concepts and industrial designs for pharmaceuticals
  • User handling review and risk-analysis
  • Prototyping initial concepts up to functional devices for patients
  • User focus groups and human factor studies for concept and prototype evaluations
  • In-depth user requirements and design specifications based on a selected medical concept

Development of pharmaceutical devices depends on the understanding of technical, regulatory and operational requirements.

Design-to-manufacturing transfer services

Haselmeier offers integrated design, development and industrialisation services to help clients bridge their serial product into the market.

The company’s qualified design control process, certified quality system, regulatory expertise, network of partners and manufacturing operations are designed to help clients achieve their goals.

Haselmeier’s commercial development and industrialisation services include:

  • Concept transfer into user requirements and product design specifications for the pharmaceutical industry
  • Design verification, product and process validation processes
  • Regulatory expertise to support an approval strategy
  • Controlled design-to-manufacturing transfer, verification and validation of self-injection devices

Haselmeier applies the highest standards for manufacturing drug delivery devices to ensure reliable manufacturing and quality processes. The company works with customers to identify product improvements at all stages of its lifecycle, to provide a safe drug delivery device.

Haselmeier provides flexible manufacturing and lifecycle management, including:

  • Certified production facilities and manufacturing processes
  • Qualified and trained personnel
  • A strong network of sub-suppliers and manufacturing partners in the pharmaceutical sector
  • Continuous engineering and product improvement programme for medical devices
  • Innovation meetings to identify next product generation

About Haselmeier

Haselmeier develops and manufactures innovative self-injection devices that feature company designs and state-of-the-art technology.

Haselmeier has more than four decades of experience in the field of medical devices. Through the years, the company has built up a top-class planning and development team that is responsible for the design, planning and industrialisation of its innovative self-injection systems. The company manufactures successful products that are used by pharmaceutical and biotechnology companies worldwide.

Headquartered in Switzerland, Haselmeier employs around 200 people worldwide. The company has sales offices in Europe, the US and India. Haselmeier’s products are manufactured in state-of-the-art production facilities in Buchen, Odenwald, Dnešice and Bengaluru.


The D-Flex is a disposable injection pen that uses 3ml cartridges. It is available in two versions that are designed to cover a freely selectable, regular or irregular dose regimen.

Organisational Changes in Quality Management at Haselmeier

Konrad Betzler was appointed the new chief quality officer (CQO) of the entire Haselmeier  Group in October 2017, with responsibility for quality management, quality assurance, and all  regulatory matters worldwide.

15 November 2017

D-Flex Pen System

The Haselmeier D-Flex is a disposable pen for use with 3ml cartridges.

22 August 2017

Haselmeier wins the German Brand Award

After winning the GOOD DESIGN™ Award and the Red Dot Award: Product Design in 2015, Haselmeier has also been crowned winner of the German Brand Award 2016.

7 September 2016

Wilhelm Haselmeier GmbH & Co. KG

Vaihinger Strasse 48
70567 Stuttgart

Haselmeier AG

Albisriederstrasse 253 (YOND)
8047 Zurich

Haselmeier Inc

126 John Street
Lowell, MA 01852
United States of America

Haselmeier India Private Limited

J.R Tech Park, Building No.1, Sy No. 27/4 A2
Yarandahalli, Bommasandra 4th Phase
Jigani Hobli, Anekal Taluk
Bangalore – 560 105

NEWSLETTER Sign up Tick the boxes of the newsletters you would like to receive. A weekly roundup of the latest news and analysis, sent every Friday. The pharmaceutical industry's most comprehensive news and information delivered every month.
I consent to GlobalData UK Limited collecting my details provided via this form in accordance with the Privacy Policy


Thank you for subscribing to Pharmaceutical Technology